Chai Discovery

Chai Discovery is developing frontier generative AI models to transform biology from an observational science into an engineering discipline. With models like Chai-3, the company designs de novo molecular compounds, therapeutic proteins, and antibodies from scratch in partnership with leading global biopharmaceutical leaders including Eli Lilly, Pfizer, and Novartis.